Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
The mechanisms underlying selective serotonin reuptake inhibitor (SSRI) use during pregnancy as a major autism risk factor are unclear. Here, brain neurochemical changes following fluoxetine exposure and in an autism model were compared to determine the effects on autism risk. The study was performe...
Main Authors: | Ramesa Shafi Bhat, Mona Alonazi, Sooad Al-Daihan, Afaf El-Ansary |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/2/310 |
Similar Items
-
Does prenatal exposure to antidepressants cause autism? - literature review
by: Zuzanna Marczyńska, et al.
Published: (2024-02-01) -
Chronic fluoxetine treatment of juvenile zebrafish (Danio rerio) does not elicit changes in basal cortisol levels and anxiety-like behavior in adulthood
by: Maureen L. Petrunich-Rutherford
Published: (2019-03-01) -
Serotonin Transporter Activity in Mouse Oocytes Is a Positive Indicator of Follicular Growth and Oocyte Maturity
by: Nina M. Alyoshina, et al.
Published: (2023-07-01) -
Maternal prenatal depression and epigenetic age deceleration: testing potentially confounding effects of prenatal stress and SSRI use
by: Brooke G. McKenna, et al.
Published: (2021-03-01) -
Bee Pollen and Probiotics May Alter Brain Neuropeptide Levels in a Rodent Model of Autism Spectrum Disorders
by: Mashael A. Alghamdi, et al.
Published: (2022-06-01)